GET THE COMPLETE DIAGNOSTIC PICTURE

GET THE COMPLETE DIAGNOSTIC PICTURE

Karius is a life sciences company focused on saving lives. We are committed to advancing diagnostic science and technology to optimize treatment for infectious disease.

The Karius Test® is a liquid biopsy for infectious diseases. From a single blood sample, the Karius Test can non-invasively and rapidly detect over 1,000 pathogens associated with both deep-seated and bloodstream infections. The Karius Test may help clinicians avoid many invasive, low-yield, and sequential diagnostic tests that can delay treatment for vulnerable hospitalized patients.

We use genomics and AI to advance infectious disease diagnostics.

Microbial Cell-Free DNA

Karius provides unique genomic insights by detecting microbial cell–free DNA (mcfDNA) circulating in the bloodstream from more than 1000 pathogens that cause infections.

AI Technology

Advanced machine learning algorithms allow analysis of complex genomic data in real time. Our proprietary reference genome databases are constantly refined as more data becomes available.

PICKUP Study

Pneumonia in the ImmunoCompromised: Use of the Karius Test for the Detection of Undiagnosed Pathogens

Existing Customer

Awards